Exemestane (Aromasin) | Cancer information - Cancer Research UK
Exemestane (Aromasin) Exemestane is a type of hormone therapy drug. It is also known as Aromasin. It is a treatment for breast cancer after you have had the menopause (post menopausal). You pronounce exemestane as ex-e-mes-tane. How does exemestane work? Many breast cancers are stimulated to grow by the female sex hormones oestrogen and ...
A trial of exemestane with or without everolimus for breast cancer …
485 women had exemestane and everolimus; 239 had exemestane and a dummy drug (placebo) Women in the everolimus group had more side effects such as sore mouth, a drop in the number of red blood cells (anaemia), shortness of breath and tiredness . The trial team followed up the women for an average of 18 months.
A trial of tamoxifen and exemestane for early breast cancer in post ...
The researchers found that having 5 years of exemestane straight away worked as well as having tamoxifen for 2 to 3 years followed by exemestane. The trial recruited over 9,000 women who had already had surgery and possibly chemotherapy for early breast cancer. Half the women took exemestane from the start.
A trial looking at everolimus, exemestane and ... - Cancer Research …
Women who had everolimus and exemestane or everolimus on its own had more problems with a sore mouth. This was a common side effect for both groups. Conclusion The trial team found that everolimus and exemestane worked better than everolimus. But the trial didn’t show that everolimus and exemestane worked better than capecitabine.
A trial of everolimus, letrozole and exemestane for advanced HER2 ...
But everolimus and exemestane didn’t work as well as they had hoped. This is because these women had a number of areas of cancer spread and they had already had everolimus. So, the researchers say that care should be taken when considering the results of this group.
A trial looking at exemestane, letrozole and celecoxib before …
Some people taking part had exemestane and some had letrozole. Alongside that, some had celecoxib and some had a dummy drug (placebo). Results A total of 266 women had treatment as part of this trial. There were 4 treatment groups. The women taking part were put into a group at random: 67 had exemestane and celecoxib; 67 had exemestane and a ...
Hormone therapy for breast cancer | Cancer Research UK
exemestane (Aromasin) You are most likely to have anastrozole or letrozole for 5 years. Or you might have one of these drugs for 2 years followed by tamoxifen for 3 years. If you can't have an aromatase inhibitor, you have tamoxifen for 5 years. Other options might include:
Food and drink to avoid during cancer treatment
Everything you take by mouth, including food, drink and medicine, needs to be absorbed by the body. This process happens in the gut (digestive system).
A trial looking at everolimus and exemestane for breast cancer …
We know from research that everolimus with exemestane works for women with advanced hormone positive breast cancer. The researchers want to find a way to work out how well the treatment has worked. To do this they will take samples of blood and tissue from women having everolimus and exemestane.
A trial looking at abiraterone with exemestane for breast cancer …
In group 1 you have abiraterone, prednisolone and exemestane. In group 2 you have abiraterone and prednisolone. In group 3 you have exemestane alone. Abiraterone is a tablet. You take 4 tablets daily on an empty stomach. You can’t eat for at least 2 hours before or 1 hour after taking your tablets. You take your tablets about the same time ...